We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




World’s First Rapid Saliva-Based Pregnancy Test Set for Multi-Country Launch

By LabMedica International staff writers
Posted on 09 Nov 2022
Print article
Image: SaliStick is the first pregnancy test that does not require urine (Photo courtesy of Salignostics)
Image: SaliStick is the first pregnancy test that does not require urine (Photo courtesy of Salignostics)

Saliva contains over 5,000 identified proteins. With significant overlap to blood, saliva is considered the second most important body-fluid for diagnostics. Now, the world’s first saliva-based pregnancy test is all set to arrive in stores across Europe, South Africa, United Arab Emirates, and Israel in the first quarter of 2023. By analyzing saliva, the test completely removes the need for blood and urine samples when testing for pregnancy.

Salistick from Salignostics (Jerusalem, Israel) is the first rapid saliva-based pregnancy test with a new and improved user-experience, and high accuracy for early pregnancy detection. The kit is based on the company’s revolutionary technology which opens the door for a sensitive detection of the pregnancy hormone β-hCG in saliva. The simple, easy to use test can be done anywhere, at any time, without the need for a restroom and delivers accurate results in no more than 10 minutes.

Salistick has already been approved by the European CE certification and has received Medical Devices and Accessories approval from Israel’s Ministry of Health. Salignostics has also completed a 510(K) initial Q-submission of SaliStick to the US FDA. In order to support the commercialization of SaliStick, Salignostics has established a new manufacturing facility in Israel with a monthly production capacity of one million units.

Related Links:
Salignostics 

New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
CVD Risk Test
GammaCoeur CVD Risk ELISA Test
New
Urine Drug Test
Instant-view Methadone Urine Drug Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.